Q3 2022 Holdings
Filed 2022-11-14 | 35 holdings | $121.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $69.8M | 2,668,316 | 57.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $21.4M | 761,398 | 17.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $9.3M | 933,743 | 7.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $8.6M | 83,500 | 7.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $7.5M | 37,300 | 6.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.2M | 224,300 | 1.8% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $1.5M | 11,300 | 1.3% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $465.0K | 20,000 | 0.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $171.0K | 2,503,059 | 0.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $50.2K | 2,551,703 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $38.7K | 624,500 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $24.5K | 2,045,442 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $22.7K | 474,929 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $19.3K | 243,400 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $15.4K | 221,000 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $13.5K | 1,324,868 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $11.4K | 533,264 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $10.8K | 243,500 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $10.3K | 220,953 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $9.8K | 763,456 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $8.8K | 1,225,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $7.8K | 34,500 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $7.4K | 331,096 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $7.1K | 2,425,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $6.2K | 379,629 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $4.0K | 499,996 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $3.9K | 200,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $3.3K | 1,400,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.2K | 579,061 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.2K | 40,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $2.6K | 75,000 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.1K | 100,000 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $861 | 1,000,000 | 0.0% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $581 | 450,000 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $145 | 30,000 | 0.0% |